| NK cells-directed therapies target circulating tumor cells and metastasis H Dianat-Moghadam, A Mahari, M Heidarifard, N Parnianfard, ... Cancer Letters, 2020 | 77 | 2020 |
| TRAIL in oncology: From recombinant TRAIL to nano-and self-targeted TRAIL-based therapies H Dianat-Moghadam, M Heidarifard, A Mahari, M Shahgolzari, ... Pharmacological research 155, 104716, 2020 | 61 | 2020 |
| Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy H Dianat-Moghadam, A Mahari, R Salahlou, M Khalili, M Azizi, ... Stem Cell Research & Therapy 13 (1), 1-12, 2022 | 51 | 2022 |
| Isochromenone-functionalized mesoporous silica hollow sphere as an efficient material for drug delivery K Naghdipari, L Shojaei, A Heidari, M Heidarifard, M Sharbati, A Mahari, ... Polyhedron 170, 659-665, 2019 | 6 | 2019 |
| A computational model of crosstalk between MAPK signaling and store-operated calcium entry in melanoma cells A Mahari, PE Stauffer, V Quaranta, LA Harris International Conferences on Systems Biology (ICSB), 2023 | | 2023 |
| Computational modeling of ER-Mitochondrial Ca2+ transfer and metabolic dysregulation in BRAF-mutant melanoma cells A Mahari, J Dykstra, L Harris Arkansas Integrated Metabolic Research Center (AIMRC), 2021 | | 2021 |
